Nettsider med emneord «NAD+»

Hilde Loge Nilsen, Principal Investigator at CRESCO, has co-authored a recent review paper published in Nature Aging. In this review, the authors summarize important data regarding the safety, bioavailability, and efficacy of NAD+ in clinical trials, focusing on aging and neurodegenerative diseases.